|
Wednesday 25th September 2019 |
Text too small? |
Abano Healthcare shares rose to a six-month high after the dental clinic operator said its board is considering competing offers - one for the whole business and one for its Australian chain.
The shares were recently up 9.1 percent at $4.68, after Abano confirmed it's in exclusive talks with two parties. The Australian Financial Review's Street Talk column today reported Australian private equity firm BGH Capital is in talks to buy Abano in full, while ASX-listed 1300 Smiles is seeking to buy the Maven Dental chain in Australia.
Abano didn't name the parties, saying confidentiality agreements are in place, but did confirm that one was for all of Abano's shares and the other was for all of Maven's shares.
"The Abano board has been undertaking a thorough process in response to the expressions of interest and will not endorse a proposal unless it is satisfied that in all the circumstances it provides a compelling proposition for shareholders," it said in a statement.
The trans-Tasman dental market is going through a period of consolidation and Abano received a number of expressions of interest in July.
Abano reiterated that there's no certainty of a deal going ahead, and said investors should consider seeking financial advice if they wish to trade in the company's shares.
(BusinessDesk)
No comments yet
RYM - Ryman Healthcare appoints new independent director
ikeGPS 4Q FY26 and Full Year FY26 Performance Update
HGH - Heartland trading update
CVT - Comvita Rights Offer Opens
GNE - FY26 Q3 Performance Report and Updated Guidance
April 23rd Morning Report
Devon Funds Morning Note - 22 April 2026
AGL - Accordant Group Limited announces opening of Rights Offer
April 22nd Morning Report
BPG - Q4 FY26 Update: ARR reaches $26.8m